A new digital medical device collects real-world data to support personalized care for people with hemophilia A and B, a study reports.

Opportunities include technological innovation, strategic partnerships, and regional market expansion to enhance operational resilience and modernize supply chains in the evolving blood plasma ...

Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how ...

“I realized I didn’t want to work in the delivery of care for individual patients,” Hayes-Mota says. “I wanted systemic ...

Hemophilia care has evolved from frequent intravenous factor replacement to more convenient nonfactor therapies with subcutaneous administration. Nonfactor therapies, including Hemlibra and ...

Hemophilia A is a rare, inherited condition that prevents your blood from clotting the way it should. People with hemophilia A do not make enough of a protein called factor VIII, which normally works ...

Novo Nordisk has a factor VIII mimetic in a phase 3 trial, and a Chinese company is forging ahead with its gene therapy product. Hemophilia, a rare X-linked, inherited bleeding disorder, affects over ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." When you bleed, your body kicks into action with a series of reactions to help blood clots form to stop ...

Study demonstrates superiority, showing both statistically significant and clinically meaningful reduction in annualized bleeding rate with a generally well-tolerated safety profile compared to ...